ADHD/anti-narcolepsy |
|
|
Androgenic Agents |
|
|
Anorexiants/Anti-Obesity |
|
|
Antiasthmatic Monoclonal Antibodies |
|
|
Antibiotics |
|
- 16.00.00.49
- 07.00.00
- 16.14.00
|
Antidepressants |
|
|
Antidiabetics |
|
|
Antihemophilic |
|
|
Antihyperlipidemics |
|
- 39.48.00
- 39.50.00.AA
- 39.35.00
|
Antiparasitics |
|
|
Antipsychotics |
|
|
Antivirals |
|
|
Atopic Dermatitis Agents |
|
- 90.27.30.20
- 90.78.40
- 90.23.00.AA
|
Bone Density Regulators |
|
|
Brands with Generic Equivalents |
|
|
Cardiovascular Agents |
|
|
Chronic GI Motility Agents
|
|
|
COVID-19 |
|
|
Corticosteroids |
|
|
Cystic Fibrosis Agents |
|
|
Cytokine and CAM Agents |
|
|
Dermatologics |
|
|
Endocrine and Metabolic Agents |
|
- 30.90.20.30
- 30.90.85.50
- 30.90.85.65
- 30.19.20.AA
- 30.90.90
- 30.90.95
|
Gout Agents |
|
|
Growth Hormone Agents |
|
|
Hormone replacement |
|
|
Hematological Agents |
|
|
Hematopoietic Agents |
|
- 82.40.10
- 82.40.15
- 82.40.50
|
Immune Modulators |
|
|
Migraine Products |
|
|
Movement Disorder Agents |
|
|
Musculoskeletal Therapy Agents |
|
|
Neuromuscular Agents |
|
- 74.50.90
- 99.40.20
- 74.70.00.AA
- 74.70.65.AA
|
Oncology |
|
- 21.40.60
- 21.10.40
- 21.60.00.45
- 21.53.40
|
Opioids |
|
- 65.10.00.50
- 65.10.00
- 65.10.00.25
|
Ophthalmics |
|
- 86.77.00.AA
- 86.37.00
- 86.73.40
|
Proton Pump Inhibitors (PPIs)
|
|
|
Psychotherapeutic and Neurological Agents – MISC : Multiple Sclerosis Agents |
|
|
Psychotherapeutic and Neurological Agents – MISC : Transthyretin Amyloidosis Agents |
|
|
Pulmonary Arterial Hypertension (PAH) Agents |
|
|
Pulmonary Fibrosis Agents |
|
|
Respiratory Agents – MISC |
|
|
Sleep Disorder Agents |
|
|